Total Payments
$467,341
2024 Payments
$66,033
Companies
24
Transactions
755
Payment Breakdown by Category
Other$386,409 (82.7%)
Travel$62,942 (13.5%)
Food & Beverage$11,895 (2.5%)
Consulting$5,500 (1.2%)
Gifts$449.40 (0.1%)
Education$146.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $386,409 | 137 | 82.7% |
| Travel and Lodging | $62,942 | 291 | 13.5% |
| Food and Beverage | $11,895 | 304 | 2.5% |
| Consulting Fee | $5,500 | 1 | 1.2% |
| Gift | $449.40 | 9 | 0.1% |
| Education | $146.75 | 13 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $198,259 | 348 | $0 (2019) |
| ABBVIE INC. | $144,976 | 173 | $0 (2024) |
| Alkermes, Inc. | $116,011 | 149 | $0 (2022) |
| Neos Therapeutics, LP | $5,922 | 13 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $253.35 | 7 | $0 (2019) |
| Shire North American Group Inc | $248.78 | 9 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $228.76 | 12 | $0 (2021) |
| Merz North America, Inc. | $193.75 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $174.40 | 6 | $0 (2018) |
| Lundbeck LLC | $172.32 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,033 | 71 | ABBVIE INC. ($65,720) |
| 2023 | $29,125 | 39 | ABBVIE INC. ($28,853) |
| 2022 | $23,532 | 35 | ABBVIE INC. ($23,426) |
| 2021 | $27,077 | 44 | AbbVie Inc. ($26,976) |
| 2019 | $104,208 | 176 | Allergan Inc. ($87,259) |
| 2018 | $166,134 | 286 | Allergan Inc. ($96,402) |
| 2017 | $51,233 | 104 | Alkermes, Inc. ($35,501) |
All Payment Transactions
755 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $102.79 | General |
| Category: PSYCHIATRY | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $24.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $34.84 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: ADHD | ||||||
| 06/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $41.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $98.56 | General |
| Category: Central Nervous System | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $307.18 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Sarit Hovav, M.D
Dr. Sarit Hovav, M.D is a Psychiatry healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1326489550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarit Hovav, M.D has received a total of $467,341 in payments from pharmaceutical and medical device companies, with $66,033 received in 2024. These payments were reported across 755 transactions from 24 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($386,409).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry, Psychiatry
- Location Omaha, NE
- Active Since 07/16/2013
- Last Updated 01/17/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1326489550
Products in Payments
- VRAYLAR (Drug) $342,774
- Aristada 441 mg (Drug) $98,903
- ARISTADA (Drug) $16,665
- Adzenys XR-ODT (Drug) $5,922
- Vivitrol 380 mg (Drug) $443.29
- REXULTI (Drug) $431.39
- NUEDEXTA (Drug) $228.76
- CAPLYTA (Drug) $224.08
- LATUDA (Drug) $174.40
- MYDAYIS (Drug) $173.47
- FETZIMA (Drug) $148.75
- BELSOMRA (Drug) $120.44
- INGREZZA (Drug) $118.24
- Austedo XR (Drug) $98.56
- Dyanavel XR (Drug) $81.87
- VYVANSE (Drug) $75.31
- Auvelity (Drug) $59.82
- INVEGA SUSTENNA (Drug) $35.60
- SUNOSI (Drug) $31.94
- Fanapt (Drug) $28.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Omaha
Vithyalakshmi Selvaraj, M.b.b.s, M.B.B.S
Psychiatry — Payments: $1.2M
Psychiatry $1.2M
Mary Jo Hanigan, Md, MD
Psychiatry — Payments: $123,744
Psychiatry $123,744
Dr. Michael Sedlacek, Md, MD
Psychiatry — Payments: $21,436
Psychiatry $21,436
Syed Sattar, M.d, M.D
Psychiatry — Payments: $17,220
Psychiatry $17,220
Dr. Elizabeth Fitzpatrick, M.d, M.D
Psychiatry — Payments: $11,881
Psychiatry $11,881
Yon Chong, M.d., M.p.h., M.b.a, M.D., M.P.H., M.B.A
Psychiatry — Payments: $7,778
Psychiatry $7,778